HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Horng-Heng Juang Selected Research

19- nor- 2- (3- hydroxypropyl)- 1,25- dihydroxyvitamin D3

7/2018MART-10, a 1α,25(OH)2D3 Analog, Potently Represses Metastasis of ER+ Breast Cancer Cells with VEGF-A Overexpression.
11/20171α,25(OH)2D3 Analog, MART-10, Inhibits Neuroendocrine Tumor Cell Metastasis After VEGF-A Stimulation.
1/2017MART-10 represses cholangiocarcinoma cell growth and high vitamin D receptor expression indicates better prognosis for cholangiocarcinoma.
7/20161α,25(OH)2D3 Analog, MART-10, Inhibits Neuroendocrine Tumor Cell Growth Through Induction of G0/G1 Cell-cycle Arrest and Apoptosis.
4/2016The Vitamin D Analog, MART-10, Attenuates Triple Negative Breast Cancer Cells Metastatic Potential.
1/2016MART-10, the new brand of 1α,25(OH)2D3 analog, is a potent anti-angiogenic agent in vivo and in vitro.
1/2016MART-10, a newly synthesized vitamin D analog, represses metastatic potential of head and neck squamous carcinoma cells.
12/2015MART-10, the vitamin D analog, is a potent drug to inhibit anaplastic thyroid cancer cell metastatic potential.
11/2014The vitamin D analog, MART-10, represses metastasis potential via downregulation of epithelial-mesenchymal transition in pancreatic cancer cells.
1/2014MART-10, a less calcemic vitamin D analog, is more potent than 1α,25-dihydroxyvitamin D3 in inhibiting the metastatic potential of MCF-7 breast cancer cells in vitro.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Horng-Heng Juang Research Topics

Disease

48Carcinoma (Carcinomatosis)
03/2023 - 03/2004
46Neoplasms (Cancer)
03/2023 - 03/2004
16Prostatic Neoplasms (Prostate Cancer)
03/2023 - 11/2004
13Carcinogenesis
03/2023 - 01/2011
12Neoplasm Metastasis (Metastasis)
07/2018 - 03/2004
10Urinary Bladder Neoplasms (Bladder Cancer)
01/2024 - 09/2007
8Breast Neoplasms (Breast Cancer)
07/2018 - 01/2012
8Hypercalcemia (Milk Alkali Syndrome)
01/2016 - 12/2011
6Cholangiocarcinoma
01/2019 - 01/2013
5Urinary Tract Infections (Urinary Tract Infection)
04/2024 - 01/2020
4Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
04/2024 - 01/2018
4Hepatocellular Carcinoma (Hepatoma)
03/2020 - 06/2005
4Hypoxia (Hypoxemia)
02/2019 - 11/2011
4Squamous Cell Carcinoma of Head and Neck
08/2016 - 11/2013
3Inflammation (Inflammations)
03/2023 - 03/2020
3Lower Urinary Tract Symptoms
03/2018 - 01/2013
2Urinary Retention
05/2024 - 01/2018
2Pain (Aches)
07/2023 - 01/2020
2Urinary Bladder Neck Obstruction (Bladder Neck Obstruction)
11/2022 - 01/2017
2Hyperplasia
01/2020 - 01/2013
2Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2017 - 07/2016
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2016 - 11/2013
2Pancreatic Neoplasms (Pancreatic Cancer)
11/2014 - 04/2013
1Hypertension (High Blood Pressure)
05/2024
1Nocturia
01/2024
1Parkinson Disease (Parkinson's Disease)
01/2024
1Shock
10/2023
1Urolithiasis
10/2023
1Urethral Stricture
08/2023
1Surgical Wound
07/2023
1Hemorrhage
02/2023

Drug/Important Bio-Agent (IBA)

15hydroxide ionIBA
07/2018 - 12/2011
14Prostate-Specific Antigen (Semenogelase)IBA
08/2023 - 11/2004
1419- nor- 2- (3- hydroxypropyl)- 1,25- dihydroxyvitamin D3IBA
07/2018 - 12/2011
13Vitamin DFDA LinkGeneric
01/2017 - 12/2011
11Proteins (Proteins, Gene)FDA Link
09/2022 - 03/2009
9AndrogensIBA
03/2023 - 05/2008
9Aconitate Hydratase (Aconitase)IBA
01/2013 - 03/2004
8SERPIN-B5 (maspin)IBA
10/2022 - 10/2012
8Interleukin-6 (Interleukin 6)IBA
03/2021 - 07/2011
6caffeic acid phenethyl esterIBA
10/2022 - 01/2017
5ThuliumIBA
04/2024 - 01/2020
5Androgen Receptors (Androgen Receptor)IBA
03/2023 - 07/2014
5matrigelIBA
10/2022 - 07/2008
5IronIBA
08/2016 - 10/2004
4Propolis (Bee Bread)IBA
10/2022 - 01/2017
4VimentinIBA
09/2022 - 11/2014
4AntioxidantsIBA
08/2022 - 04/2018
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 11/2011
3Analgesics (Analgesic Drugs)IBA
07/2023 - 01/2020
3Growth Differentiation Factor 15IBA
10/2022 - 08/2015
3Heme Oxygenase-1IBA
08/2022 - 01/2020
3Messenger RNA (mRNA)IBA
08/2022 - 07/2008
3ArsenicIBA
04/2020 - 10/2013
3Serine Proteinase Inhibitors (Serine Protease Inhibitors)IBA
12/2019 - 08/2015
3Calcitriol Receptors (Calcitriol Receptor)IBA
01/2017 - 06/2014
3Chelating AgentsIBA
08/2016 - 02/2012
3DNA (Deoxyribonucleic Acid)IBA
07/2014 - 01/2013
3ThymidineIBA
10/2013 - 02/2012
3MimosineIBA
01/2013 - 11/2011
3matriptaseIBA
10/2012 - 07/2008
2Testosterone (Sustanon)FDA Link
08/2023 - 11/2022
2Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinIBA
03/2023 - 03/2021
2Cadherins (E-Cadherin)IBA
09/2022 - 05/2016
2MetallothioneinIBA
08/2022 - 02/2019
2Transforming Growth Factors (Transforming Growth Factor)IBA
07/2022 - 10/2012
2Antineoplastic Agents (Antineoplastics)IBA
01/2022 - 01/2012
2CadmiumIBA
04/2020 - 10/2013
2Metallothionein 3IBA
02/2019 - 10/2013
2Estrogen ReceptorsIBA
07/2018 - 01/2012
2capillarisinIBA
04/2018 - 01/2018
2MineralsIBA
01/2017 - 01/2016
225-Hydroxyvitamin D3 1-alpha-Hydroxylase (25 Hydroxyvitamin D3 1 alpha Hydroxylase)IBA
08/2016 - 11/2015
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
08/2016 - 01/2015
2TensinsIBA
08/2016 - 01/2015
2Hormones (Hormone)IBA
01/2015 - 01/2012
2CytokinesIBA
01/2014 - 01/2013
2AgarIBA
10/2012 - 09/2012
2Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
02/2012 - 11/2011
2EnzymesIBA
11/2011 - 01/2011
2CurcuminIBA
11/2011 - 11/2008
2Citric Acid (Citrate)FDA LinkGeneric
01/2011 - 03/2004
2Triiodothyronine (Liothyronine)FDA LinkGeneric
05/2008 - 05/2005
2Adenosine (Adenocard)FDA LinkGeneric
09/2004 - 04/2004
1CarcinogensIBA
01/2024
1MelatoninIBA
01/2024
1Hemoglobins (Hemoglobin)IBA
02/2023
15-ethynyl-2'-deoxyuridineIBA
10/2022

Therapy/Procedure

5Lasers (Laser)
02/2023 - 01/2013
5Transurethral Resection of Prostate (TURP)
01/2020 - 01/2017
4Radiotherapy
10/2016 - 01/2012
4Therapeutics
01/2015 - 01/2012
3Length of Stay
05/2024 - 07/2023
2Drug Therapy (Chemotherapy)
10/2016 - 04/2013
2Prostatectomy (Retropubic Prostatectomy)
01/2015 - 01/2013
1Catheters
05/2024
1Solid-State Lasers
04/2024
1Lithotripsy (Extracorporeal Shockwave Lithotripsy)
10/2023
1Operative Time
07/2023
1Eye Enucleation (Enucleation, Eye)
11/2022